Schwab Charles Investment Management Inc. Sells 107,008 Shares of Halyard Health, Inc. (HYH)

Schwab Charles Investment Management Inc. reduced its stake in shares of Halyard Health, Inc. (NYSE:HYH) by 13.4% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 690,985 shares of the medical instruments supplier’s stock after selling 107,008 shares during the period. Schwab Charles Investment Management Inc. owned about 1.48% of Halyard Health worth $31,116,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of HYH. Renaissance Technologies LLC bought a new stake in Halyard Health during the 1st quarter worth approximately $727,000. Capstone Asset Management Co. increased its holdings in Halyard Health by 6.2% during the 2nd quarter. Capstone Asset Management Co. now owns 5,663 shares of the medical instruments supplier’s stock worth $222,000 after purchasing an additional 330 shares in the last quarter. Aperio Group LLC increased its holdings in Halyard Health by 7.1% during the 2nd quarter. Aperio Group LLC now owns 30,062 shares of the medical instruments supplier’s stock worth $1,181,000 after purchasing an additional 1,991 shares in the last quarter. Great West Life Assurance Co. Can increased its holdings in Halyard Health by 4.9% during the 2nd quarter. Great West Life Assurance Co. Can now owns 27,909 shares of the medical instruments supplier’s stock worth $1,096,000 after purchasing an additional 1,311 shares in the last quarter. Finally, Bessemer Group Inc. increased its holdings in Halyard Health by 73.2% during the 2nd quarter. Bessemer Group Inc. now owns 22,947 shares of the medical instruments supplier’s stock worth $901,000 after purchasing an additional 9,700 shares in the last quarter. 90.31% of the stock is owned by hedge funds and other institutional investors.

Shares of Halyard Health, Inc. (NYSE HYH) traded up $0.33 during midday trading on Monday, hitting $47.45. The stock had a trading volume of 228,400 shares, compared to its average volume of 346,159. Halyard Health, Inc. has a 12-month low of $35.24 and a 12-month high of $50.99. The stock has a market cap of $2,222.39, a P/E ratio of 22.70, a PEG ratio of 2.56 and a beta of 1.77. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.13 and a quick ratio of 1.19.

Halyard Health (NYSE:HYH) last announced its earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.13. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. The firm had revenue of $401.40 million for the quarter, compared to the consensus estimate of $394.54 million. During the same quarter in the previous year, the business earned $0.48 EPS. The company’s revenue was up 1.0% compared to the same quarter last year. research analysts expect that Halyard Health, Inc. will post 2.08 earnings per share for the current fiscal year.

A number of equities analysts have recently weighed in on the company. Zacks Investment Research upgraded Halyard Health from a “hold” rating to a “buy” rating and set a $53.00 target price on the stock in a research note on Wednesday, December 6th. TheStreet upgraded Halyard Health from a “c+” rating to a “b” rating in a research note on Monday, December 4th. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 4th. Stifel Nicolaus restated a “buy” rating and issued a $52.00 target price on shares of Halyard Health in a research note on Friday, November 3rd. Finally, KeyCorp restated a “hold” rating on shares of Halyard Health in a research note on Tuesday, October 17th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Halyard Health has an average rating of “Buy” and a consensus price target of $46.25.

COPYRIGHT VIOLATION NOTICE: “Schwab Charles Investment Management Inc. Sells 107,008 Shares of Halyard Health, Inc. (HYH)” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://ledgergazette.com/2017/12/11/schwab-charles-investment-management-inc-sells-107008-shares-of-halyard-health-inc-hyh.html.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply